News
Centre for Genomic Regulation teams up with Almirall to develop new preclinical models for...
Global biopharmaceutical company Almirall has entered into a research collaboration with the Centre for Genomic Regulation (CRG), an international biomedical research institute of excellence....
Y-mAbs’ DANYELZA approved in Brazil for the treatment of high-risk neuroblastoma
The Brazilian Health Regulatory Agency, Agência Nacional de Vigilância Sanitária (Anvisa) has granted marketing authorization for Y-mAbs Therapeutics' DANYELZA (naxitamab-gqgk) 40mg/10mL injection. DANYELZA will...
Innoviva Specialty Therapeutics receives FDA approval for pneumonia treatment XACDURO
The U.S. Food and Drug Administration (FDA) has approved Innoviva Specialty Therapeutics' XACDURO (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use in...
